Berberine inhibits Wilms' tumor cell progression through upregulation of Wilms' tumor gene on the X chromosome

Molecular Medicine Reports

Volumn 8, Issue 5, 2013, Pages 1537-1541

  Liu, Yan ^a   Liu, Sheng ^b  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

AMP activated protein kinase; Berberine; Wilms' tumor; WTX

Indexed keywords

ADENYLATE KINASE; BERBERINE; CYCLIN E; PROTEIN P21; PROTEIN P27; SMALL INTERFERING RNA;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEPHROBLASTOMA; TUMOR SUPPRESSOR GENE; UPREGULATION; X CHROMOSOME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BERBERINE; BLOTTING, WESTERN; CELL PROLIFERATION; CHROMOSOMES, HUMAN, X; HUMANS; KIDNEY NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; WILMS TUMOR;

EID: 84885154003     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1665     Document Type: Article

References (25)

1. Scott RH, Stiller CA, Walker L and Rahman N: Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 43: 705-715, 2006.
2. Malkin D, Sexsmith E, Yeger H, Williams BR and Coppes MJ: Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor. Cancer Res 54: 2077-2079, 1994.
3. Grundy PE, Breslow NE, Li S, et al; National Wilms Tumor Study Group: Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23: 7312-7321, 2005.
4. Rivera MN, Kim WJ, Wells J, et al: An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315: 642-645, 2007.
5. Major MB, Camp ND, Berndt JD, et al: Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316: 1043-1046, 2007.
6. Rivera MN and Haber DA: Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5: 699-712, 2005.
7. Kim WJ, Rivera MN, Coffman EJ and Haber DA: The WTX tumor suppressor enhances p53 acetylation 9 by CBP/p300. Mol Cell 45: 587-597, 2012.
8. Hou Q, Tang X, Liu H, et al: Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147. Cancer Sci 102: 1287-1292, 2011.
9. James MA, Fu H, Liu Y, Chen DR and You M: Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis. Mol Carcinog 50: 1-7, 2011.
10. Harikumar KB, Kuttan G and Kuttan R: Inhibition of progression of erythroleukemia induced by Friend virus in BALB/c mice by natural products - berberine, curcumin and picroliv. J Exp Ther Oncol 7: 275-284, 2008.
11. Yan K, Zhang C, Feng J, et al: Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur J Pharmacol 661: 1-7, 2011.
12. Kim S, Han J, Kim NY, et al: Effect of berberine on p53 expression by TPA in breast cancer cells. Oncol Rep 27: 210-215, 2012.
13. Meeran SM, Katiyar S and Katiyar SK: Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 229: 33-43, 2008.
14. Lv X, Yu X, Wang Y, et al: Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. PLoS One 7: e47351, 2012.
15. Tillhon M, Guamán Ortiz LM, Lombardi P and Scovassi AI: Berberine: new perspectives for old remedies. Biochem Pharmacol 84: 1260-1267, 2012.
16. Kim S, Han J, Lee SK, et al: Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells. J Surg Res 176: e21-e29, 2012.
17. Chitra P, Saiprasad G, Manikandan R and Sudhandiran G: Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependent TGF-β activation: a biphasic experimental study. Toxicol Lett 219: 178-193, 2013.
18. Alzamora R, O'Mahony F, Ko WH, Yip TW, Carter D, Irnaten M and Harvey BJ: Berberine reduces cAMP-induced chloride secretion in T84 human colonic carcinoma cells through inhibition of basolateral KCNQ1 channels. Front Physiol 2: 33, 2011.
19. Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS and Lim JS: Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol 83: 385-394, 2012.
20. Kim MK, Min DJ, Rabin M and Licht JD: Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants. Oncogene 30: 832-842, 2011.
21. Hardie DG: AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 25: 1895-1908, 2011.
22. Egan DF, Shackelford DB, Mihaylova MM, et al: Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456-461, 2011.
23. Gwinn DM, Shackelford DB, Egan DF, et al: AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226, 2008.
24. Liu L, Ulbrich J, Müller J, et al: Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 483: 608-612, 2012.
25. Jones RG, Plas DR, Kubek S, et al: AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283-293, 2005.